What is Glaukos's R&D?

Glaukos (GKOS) reported R&D of $44.15M in Q1 2026.

How has Glaukos's R&D changed year-over-year?

Glaukos's R&D increased by 36.4% year-over-year, from $32.35M to $44.15M.

What is the long-term trend for Glaukos's R&D?

Over 4 years (2021 to 2025), Glaukos's R&D has grown at a 10.5% compound annual growth rate (CAGR), from $101M to $150.61M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Glaukos GKOS R&D

R&D at other companies

Regeneron PharmaceuticalsREGN

$1.54B+16.3%

The Cooper Companies, Inc.COO

$42.5M-6.6%

ExelixisEXEL

$199.92M-5.8%

Segments

By segment

See full

Development And Commercialization Of Ophthalmic Therapies$28.97M+26.4%

Other financials

Income statement

See full

Revenue$150.6M+41.2%

Gross profit$117.2M+42.4%

Operating income-$19.9M+4.0%

Net income-$19.8M-9.0%

EPS (diluted)-$0.34-6.3%

Balance sheet

See full

Cash & equivalents$104.2M-8.8%

Total debt$105.9M-1.7%

Total equity$670.9M-12.2%

Total assets$893.3M-7.5%

Cash flow

See full

Operating cash flow-$12.5M+32.4%

CapEx$4.0M+104%

Free cash flow-$16.5M+19.4%

Valuation

See full

Market cap$7.68B+12.3%

Enterprise value$7.68B+12.5%

P/S13.9×-3.0×

Profitability

See full

Gross margin78.1%+2.3pp

Operating margin-36.1%+24.3pp

Net margin-34.3%+4.8pp

FCF margin-13.2%-3.9pp

Returns & leverage

See full

Return on equity-26.4%+11.1pp

Debt / equity0.2×0.0×

Current ratio5.4×-1.1×

Where this comes from

Reported directly by Glaukos in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Glaukos’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Glaukos's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Glaukos's R&D?: Glaukos (GKOS) reported R&D of $44.15M in Q1 2026.
How has Glaukos's R&D changed year-over-year?: Glaukos's R&D increased by 36.4% year-over-year, from $32.35M to $44.15M.
What is the long-term trend for Glaukos's R&D?: Over 4 years (2021 to 2025), Glaukos's R&D has grown at a 10.5% compound annual growth rate (CAGR), from $101M to $150.61M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.